Biodistribution studies of 99mTc-labeled myoblasts in a murine model of muscular dystrophy

Nuclear Medicine and Biology

Volumn 28, Issue 8, 2001, Pages 935-940

  Colombo, F R ^a   Torrente, Y ^b   Casati, R ^a   Benti, R ^a   Corti, S ^a   Salani, S ^c   D'Angelo M G ^c   DeLiso, A ^a   Scarlato, G ^a   Bresolin, N ^a   Gerundini, P ^a  

^a FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

^c SCIENTIFIC INSTITUTE   (Italy)

Author keywords

99mTc; Dystrophy; Gene therapy; Myoblast transplantation

Indexed keywords

BIS(2 ETHOXYETHYL)DIPHOSPHINOETHANE TECHNETIUM TC 99M; BIS(N ETHOXY)DITHIOCARBAMATE TECHNETIUM TC 99M; BIS(N ETHYL)DITHIOCABAMATE TECHNETIUM TC 99M; HEXAMETHYLPROPYLENE AMINE OXIME TECHNETIUM TC 99M; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; RADIOPHARMACEUTICAL AGENT; TETROFOSMIN TC 99M; UNCLASSIFIED DRUG; TECHNETIUM;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIODIVERSITY; CELLULAR PARAMETERS; CONTROLLED STUDY; DUCHENNE MUSCULAR DYSTROPHY; GENE TRANSFER; MOUSE; MYOBLAST; NONHUMAN; RADIOACTIVITY; ANIMAL; ANIMAL MUSCULAR DYSTROPHY; C57BL MOUSE; CELL CULTURE; CELL TRANSPLANTATION; CYTOLOGY; GENE THERAPY; METABOLISM; SKELETAL MUSCLE; TISSUE DISTRIBUTION; TRANSPLANTATION;

ANIMALS; CELL TRANSPLANTATION; CELLS, CULTURED; GENE THERAPY; MICE; MICE, INBRED C57BL; MUSCLE, SKELETAL; MUSCULAR DYSTROPHY, ANIMAL; TECHNETIUM; TISSUE DISTRIBUTION;

EID: 0034746803     PISSN: 09698051     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0969-8051(01)00256-6     Document Type: Article

References (19)

1. Intra-aortic injection of myoblasts in mdx mice: Genetic and Tc-99m cell labelling and biodistribution
2. Muscle regeneration by bone marrow-derived myogenic progenitors
3. Normal dystrophin transcripts detected in Duchenne muscular dystrophy patients after myoblast transplantation
4. The fate of individual myoblasts after transplantation into muscles of DMD patients
5. Dystrophin expression in the mdx mouse restored by stem cell transplantation
6. Primary structure of dystrophin-associated glycoproteins linking dystrophin to the extracellular matrix
7. The potential for gene therapy in Duchenne muscular dystrophy and other genetic muscle diseases
8. Complete cloning of the Duchenne muscular dystrophy (DMD) cDNA and preliminary genomic organization of the DMD gene in normal and affected individuals
9. Comparison of neutral and cationic myocardial perfusion agents; characteristics of accumulation in cultured cells
10. Myoblast transfer in the treatment of Duchenne's muscular dystrophy
11. Arterial delivery of myoblasts to skeletal muscle
12. Conversion of mdx myofibers from dystrophin-negative to positive by injection of normal myoblasts
13. Synthesis and characterization of the neutral myocardial agent (99mTcN(noet)2)
14. Bis(dithiocarbamate) nitride technetium-99m radiopharmaceuticals: A class of neutral myocardial imaging agent
15. Dystrophin protects the sarcolemma from stresses developed durig muscle contraction
16. The in vitro cultivation and differentiation capacities of myogenic cell lines
17. The molecular basis of muscular dystrophy in the mdx mouse: A point mutation
18. Results of a triple blind clinical study of myoblast transplantations without immunosuppressive treatment in young boys with Duchenne muscular dystrophy